SynthesisBMJ global health2025
Prevalence and determinants of e-cigarette use in South Asia: a systematic review.
Synthesis in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionE-cigarette use has become a significant global public health concern. Recently, several systematic reviews have synthesised evidence on e-cigarette use in Europe, America and Southeast Asia. However, there is no known systematic review of such on South Asia (SA). This systematic review aimed to systematically synthesise empirical evidence on the prevalence and determinants of e-cigarette use in SA.
methodsThis systematic review adhered to Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines and Cochrane Handbook for Systematic Reviews of Interventions. Nine databases, as well as additional sources, were searched to retrieve relevant articles on the prevalence and determinants of e-cigarette use in SA. Only those peer-reviewed articles which met the eligibility criteria were included in this systematic review. Data were extracted from the included articles and synthesised using a narrative synthesis approach.
resultsSeventeen articles were included in this systematic review and all were graded as above average after quality appraisal. Lifetime prevalence of e-cigarette use was reported in three SA countries only: India (0.1-23.8%), Bangladesh (0.4-0.5%) and Nepal (21.2%). The prevalence of current e-cigarette use was reported in four SA countries only: Pakistan (6.20-10.1%), India (0.01-5.39%), Nepal (5.9%) and Bangladesh (0.5%). The following factors were the reported determinants of e-cigarette use that were significant (p<0.05) among SA populations: self-perception of e-cigarette use as addictive, less harmful, an alternative to tobacco smoking and as a safe product; leisure use; individual appeal to the flavours of e-cigarette; individual stress; presence of mental depression; peer influence; social acceptance of e-cigarette use and prices of e-cigarettes.
conclusionEmpirical evidence on e-cigarette use is limited to specific sociodemographic, socioeconomic and geographical regions in SA. Additional empirical investigations are required to outline the prevalence and determinants of e-cigarette use in SA countries lacking adequate data. Also, there is a need for tailored interventions targeting e-cigarette use in SA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.